Yeni Koronavirüs (2019-nCoV/COVID-19) ve Vitamin C

Abstract

For the first time in December 2019, a case of pneumonia of unknown etiology was reported in Wuhan, China. Then, in addition to China and on the basis of increasing incidence and mortality rates in other international countries, the global emergency health status was declared by the World Health Organization Emergency Committee, and a new coronavirus was reported.Due to the very high contagion rate of the new Coronavirus (COVID-19), it has affected and continues to affect quite a lot of people from all age groups in the world. General clinical signs of COVID-19 are high fever, cough, nasal congestion, dyspnea, myalgia, fatigue, upper and lower respiratory tract infection and diarrhea. The most important and fatal clinical sign of the virus has been described as pneumonia. Unfortunately, no vaccine or special antiviral drug has been developed against COVID-19 yet. Therefore, the purpose of this review is to examine whether intravenous vitamin C administration is a promising method for the COVID-19 pandemic in accordance with the most recent evidence. Using vitamin C to prevent or treat diseases is often classified in complementary and alternative medicine. For this reason, it should never prevent the actual treatment. Studies have found that high doses of vitamin C reduce lung damage in COVID-19 and other flu infections. Therefore, intravenous vitamin C administration may be useful in addition to COVID-19 treatment.There is a need for high-level clinical studies on the effect of Vitamin C administration on COVID-19.